Indian drugmaker orders inspections of all drug plants as toxic cough syrup deaths renew scrutiny

“In case any manufacturing unit is found non-complying with the requirements of revised Schedule M during inspections, strict action shall be initiated,” Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi said in a notice, calling the matter a “top priority.”